heart iconheart icon
Skip to content

News Releases

 
News Releases
  Date Title and Summary View
Jul 18, 2000
NEW BRUNSWICK, N.J., July 18 -- Johnson & Johnson (NYSE: JNJ) today announced record sales of $7.5 billion and record net earnings of $1.3 billion for the second quarter of 2000, increases of 7.7% and 14.3%, respectively, over 1999 second-quarter results. Diluted earnings per share for the second quarter were $.94, up 14.6% from the same period in ...
Jun 25, 2000
JACKSONVILLE, Fla., July 25 -- According to a recent Roper Starch survey of American adults, 67 percent currently wear some form of vision correction. Yet, making sense of the latest vision care information can prove difficult for some. While the eye care survey found that eight out of 10 adults believe they understand all the eye care options avai...
Jun 22, 2000
JACKSONVILLE, Fla., June 22 -- The VISTAKON® Division of Johnson & Johnson Vision Care, Inc. announced today the availability of the ACUVUE® Brand TORIC Contact Lens, featuring a breakthrough Dual Thin Zone Stabilization Design that enhances patient satisfaction and increases ...
May 12, 2000
FORT WASHINGTON, Pa.--May 1, 2000--McNeil Consumer Healthcare today announced the national introduction of Motrin® Migraine Pain, the first over-the-counter (OTC) ibuprofen product in the rapidly growing OTC migraine category. Motrin Migraine Pain was approved by the U.S. Food and Drug Administration (FDA) on Feb...
Apr 19, 2000
NEW BRUNSWICK, N.J., April 19 -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 14.3% increase in the quarterly dividend rate, from $0.28 per share to $0.32 per share. The increase was announced this morning at the Annual Shareowners Meeting in New Brunswick, NJ. "In recognition of our strong financ...
Apr 18, 2000
NEW BRUNSWICK, N.J., April 18 -- Johnson & Johnson (NYSE: JNJ) today announced record sales of $7.3 billion and record net earnings of $1.3 billion for the first quarter of 2000, increases of 8.6% and 15.5%, respectively, over 1999 first-quarter results. Diluted earnings per share for the first quarter were $.93, up 16.3% from the same period in 19...
Apr 4, 2000
NEW BRUNSWICK, N.J., April 4-- Cordis Corporation, a wholly owned unit of Johnson & Johnson (NYSE: JNJ), today reported it has entered into an agreement with Guidant Corporation (NYSE: GDT) (PCX: GDT) that will enable Cordis to market and sell rapid exchange catheters and stent delivery systems to its U.S. customers. Each company also will g...
Mar 29, 2000
NEW YORK----March 29, 2000-- Exchange will make it faster, easier and less expensive for healthcare customers and companies to conduct business Johnson & Johnson, GE Medical Systems, Baxter International Inc., Abbott Laboratories and Medtronic, Inc. announced today that they are creating a global hea...
Mar 14, 2000
ANAHEIM, Calif., March 14 -- Preliminary six-month angiographic and nine-month clinical results of a newly completed landmark clinical trial using a catheter-based, gamma radiation (Iridium-192) ribbon for reduction of in-stent restenosis (patients with reoccluded or reclogged stents) indicates this treatment significantly reduces repeat blockage a...
Mar 13, 2000
NEW BRUNSWICK, N.J., March 13 -- The arbitrator presiding over Amgen's attempt to terminate Ortho Biotech's license to sell PROCRIT in the United States has denied motions for summary judgment by both parties, but ruled "the termination issue is barred for the present for failure of the contractually required notice." Judge Frank McGarr rule...
Page: FirstPrevious ...
163
NextLast
= add release to Briefcase